Evidence-Based Complementary and Alternative Medicine has retracted the article titled “Effects of Tenofovir Combined with Recombinant Human Interferon α-2b on Negative Conversion Rate, Liver Function, Immune Status, and Drug Safety in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis” [1] due to concerns that the peer review process has been compromised.
Following an investigation conducted by the Hindawi Research Integrity team [2], significant concerns were identified with the peer reviewers assigned to this article; the investigation has concluded that the peer review process was compromised. We therefore can no longer trust the peer review process, and the article is being retracted with the agreement of the Chief Editor.
References
- 1.Zhang H., Xian J., Li Y., Xiao L., Wang L. Effects of Tenofovir Combined with Recombinant Human Interferon α-2b on Negative Conversion Rate, Liver Function, Immune Status, and Drug Safety in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine . 2022;2022:8. doi: 10.1155/2022/1889628.1889628 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 2.Ferguson L. Advancing Research Integrity Collaboratively and with Vigour. 2022. https://www.hindawi.com/post/advancing-research-integrity-collaboratively-and-vigour/